Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Carter's
CRI
$1.42B
| $95.1M | 0.02% |
1,123,547
+265,638
| +31% | +$21.1M |
|
627
Rollins
ROL
$18.3B
| $95.1M | 0.02% |
2,055,985
+46,981
| +2% | +$2.07M |
|
628
EPAM Systems
EPAM
$5.51B
| $94.8M | 0.02% |
343,399
-50,812
| -13% | -$15M |
|
629
Natera
NTRA
$38.3B
| $94.6M | 0.02% |
1,034,545
+36,636
| +4% | +$2.76M |
|
630
Southwest Airlines
LUV
$22B
| $94.5M | 0.02% |
3,238,838
+50,490
| +2% | +$1.56M |
|
631
F5
FFIV
$22.9B
| $94.2M | 0.02% |
496,885
-746
| -0.1% | -$138K |
|
632
Albemarle
ALB
$13.9B
| $94.2M | 0.02% |
714,742
+31,030
| +5% | +$3.82M |
|
633
Teleflex
TFX
$6.05B
| $93.9M | 0.02% |
415,332
+10,129
| +2% | +$2.41M |
|
634
UFP Industries
UFPI
$4.9B
| $93.6M | 0.02% |
761,147
+7,588
| +1% | +$882K |
|
635
Chord Energy
CHRD
$7.9B
| $93.4M | 0.02% |
524,103
+27,015
| +5% | +$4.34M |
|
|
BLD
636
DELISTED
TopBuild
BLD
| $92.9M | 0.02% |
210,681
-59,413
| -22% | -$23.2M |
|
637
The Ensign Group
ENSG
$10.4B
| $92.8M | 0.02% |
746,149
+13,983
| +2% | +$1.68M |
|
638
MongoDB
MDB
$27.1B
| $92.5M | 0.02% |
257,795
+8,673
| +3% | +$3.54M |
|
639
Burlington
BURL
$23.2B
| $92.2M | 0.02% |
396,944
+612
| +0.2% | +$125K |
|
640
Akamai
AKAM
$16.7B
| $92.1M | 0.02% |
846,595
+8,054
| +1% | +$928K |
|
641
Match Group
MTCH
$9.19B
| $92M | 0.02% |
2,536,140
+69,303
| +3% | +$2.51M |
|
642
United Therapeutics
UTHR
$25.8B
| $91.5M | 0.02% |
398,437
+79,407
| +25% | +$17.9M |
|
643
Eagle Materials
EXP
$6.29B
| $91.1M | 0.02% |
335,121
+2,587
| +0.8% | +$611K |
|
|
CTLT
644
DELISTED
CATALENT, INC.
CTLT
| $91M | 0.02% |
1,612,137
+51,667
| +3% | +$2.8M |
|
645
iShares Russell 2000 Value ETF
IWN
$14.3B
| $90.9M | 0.02% |
572,202
+34,739
| +6% | +$5.26M |
|
646
PVH
PVH
$4B
| $90.8M | 0.02% |
645,955
+2,254
| +0.4% | +$288K |
|
647
Bank of Hawaii
BOH
$3.15B
| $90.6M | 0.02% |
1,451,505
+309,382
| +27% | +$19.6M |
|
648
Quest Diagnostics
DGX
$25.7B
| $90.6M | 0.02% |
680,325
+16,408
| +2% | +$2.13M |
|
649
American Airlines Group
AAL
$10.1B
| $90.3M | 0.02% |
5,879,890
+67,630
| +1% | +$981K |
|
650
Ralph Lauren
RL
$22.6B
| $90.2M | 0.02% |
480,217
+5,885
| +1% | +$974K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.